Redox Biology, [online] 6, pp.198205
Innovator pricing abroad is still high, generic competition is thin, and the 5,000-crore incremental opportunity Systematix talks about is, in the analysts own framing, largely an export number concentrated in far fewer hands than the domestic chaos suggests
In my new podcast, GLP-1 Truth Serum, Ill bring my 10+ years of experience studying the negative effects of the diet industry and size-based discrimination, to tell a different story about this weight-loss craze
2009 Brown Nancy
Beyond BED, bulimia nervosa (BN) also shares core features of impulsive, dysregulated eating and recurrent binge episodes, and GLP-1related satiety and reward pathways are likely relevant in both conditions [21]